Leaflet SUGAMMADEX AGUETTANT 50mg / ml solution for injection in pre-filled syringe


Indicated for: reversal of neuromuscular blockade

Route of administration: injectable

Substance: sugamadex (neuromuscular blocker)

ATC: V03AB35 (Various | All other therapeutic products | Antidotes)

Sugammadex is a reversal agent used to counteract the effects of neuromuscular blockers such as rocuronium and vecuronium after surgical procedures. It works by directly binding to the neuromuscular blocking agents, facilitating the recovery of muscle function.

The medication is administered intravenously, as directed by a doctor, usually at the end of surgery. It is important for administration to be performed under medical supervision.

Patients should be aware of potential side effects, such as nausea, hypotension, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, hypotension, and headache. In rare cases, severe reactions such as anaphylactic reactions may occur. Patients should be informed of these risks before administration.

General data about SUGAMMADEX AGUETTANT 50mg / ml

  • Substance: sugamadex
  • Date of last drug list: 01-02-2024
  • Commercial code: W69925001
  • Concentration: 50mg / ml
  • Pharmaceutical form: solution for injection in pre-filled syringe
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: LABORATOIRE AGUETTANT - FRANTA
  • Holder: LABORATOIRE AGUETTANT - FRANTA
  • Number: 15243/2023/01
  • Shelf life: 2 years-after packing for marketing;after the first opening-it is used immediately

Pharmaceutical forms available for sugamadex

Concentrations available for sugamadex

  • 100mg/ml
  • 10mg/ml
  • 50mg/ml